CA2040510A1 - Composition et traitement faisant appel a des peptides biologiquement actifs et a des cations toxiques - Google Patents

Composition et traitement faisant appel a des peptides biologiquement actifs et a des cations toxiques

Info

Publication number
CA2040510A1
CA2040510A1 CA002040510A CA2040510A CA2040510A1 CA 2040510 A1 CA2040510 A1 CA 2040510A1 CA 002040510 A CA002040510 A CA 002040510A CA 2040510 A CA2040510 A CA 2040510A CA 2040510 A1 CA2040510 A1 CA 2040510A1
Authority
CA
Canada
Prior art keywords
peptide
cations
amino acid
composition
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002040510A
Other languages
English (en)
Inventor
Barry Berkowitz
Leonard Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Barry Berkowitz
Leonard Jacob
Magainin Sciences Inc.
Magainin Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barry Berkowitz, Leonard Jacob, Magainin Sciences Inc., Magainin Pharmaceuticals, Inc. filed Critical Barry Berkowitz
Publication of CA2040510A1 publication Critical patent/CA2040510A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
CA002040510A 1990-04-23 1991-04-22 Composition et traitement faisant appel a des peptides biologiquement actifs et a des cations toxiques Abandoned CA2040510A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51234590A 1990-04-23 1990-04-23
US512,345 1990-04-23

Publications (1)

Publication Number Publication Date
CA2040510A1 true CA2040510A1 (fr) 1991-10-24

Family

ID=24038703

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002040510A Abandoned CA2040510A1 (fr) 1990-04-23 1991-04-22 Composition et traitement faisant appel a des peptides biologiquement actifs et a des cations toxiques

Country Status (4)

Country Link
EP (1) EP0528861A4 (fr)
JP (1) JPH05509295A (fr)
CA (1) CA2040510A1 (fr)
WO (1) WO1991016066A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US6297215B1 (en) 1995-06-02 2001-10-02 The University Of British Columbia Antimicrobial cationic peptides
US7390873B2 (en) 1995-08-23 2008-06-24 University Of British Columbia Antimicrobial cationic peptides

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348445B1 (en) 1992-06-01 2002-02-19 Magainin Pharmaceuticals, Inc. Biologically active peptides with reduced toxicity in animals and a method for preparing same
US5654274A (en) * 1992-06-01 1997-08-05 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions
US5607914A (en) * 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
AU730307B2 (en) * 1995-11-14 2001-03-01 Xoma Corporation Bactericidal permeability increasing protein (BPI) for treating conditions associated with corneal injury
GB9817224D0 (en) * 1998-08-08 1998-10-07 Univ Nottingham Ocular surface infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
AU609118B2 (en) * 1987-03-04 1991-04-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The New synthetic bioactive compounds and method of producing bioactive effect

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US6297215B1 (en) 1995-06-02 2001-10-02 The University Of British Columbia Antimicrobial cationic peptides
US6465429B1 (en) 1995-06-02 2002-10-15 The University Of British Columbia Antimicrobial cationic peptides
US6906035B2 (en) 1995-06-02 2005-06-14 The University Of British Columbia Antimicrobial cationic peptides
US7390873B2 (en) 1995-08-23 2008-06-24 University Of British Columbia Antimicrobial cationic peptides

Also Published As

Publication number Publication date
JPH05509295A (ja) 1993-12-22
WO1991016066A1 (fr) 1991-10-31
EP0528861A1 (fr) 1993-03-03
EP0528861A4 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
US5221664A (en) Composition and treatment with biologically active peptides and toxic cations
EP0505497B1 (fr) Traitement des plaies utilisant des peptides biologiquement actifs
EP0667871A1 (fr) Compositions peptidiques amphiphiles biologiquement actives et utilisations desdites compositions
CA2086111A1 (fr) Compositions a base de peptides bioactifs et utilisations
US5217956A (en) Composition and treatment with biologically active peptides and certain anions
US5208220A (en) Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
CA2107674A1 (fr) Nouvelles compositions peptidiques et leur utilisation
CA2040510A1 (fr) Composition et traitement faisant appel a des peptides biologiquement actifs et a des cations toxiques
US5654274A (en) Biologically active peptides having N-terminal substitutions
EP0590044A4 (en) Composition and treatment with biologically active peptides having c-terminal substitutions
CA2125494A1 (fr) Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs
EP0441832B1 (fr) Composition et traitement a l'aide et peptides a activite biologique et certains anions
US5459237A (en) Peptide compositions and uses therefor
CA2042468A1 (fr) Compositions et traitement de peptides biologiquement actifs contenant des residus d'acides d-amines
CA2180748A1 (fr) Peptides amphiphiliques formant des canaux ioniques et presentant des modifications n-terminales
EP0526570A4 (en) Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
EP0455719A4 (en) Composition and treatment with peptide combinations
WO1992000090A1 (fr) COMPOSITION ET TRAITEMENT A L'AIDE DE PEPTIDES BIOLOGIQUEMENT ACTIFS ET D'ANTIBIOTIQUES INHIBANT LA GYRASE d'ADN
EP1001800A2 (fr) Peptides biologiquement actifs a toxicite reduite chez l'animal et procedes d'elaboration
KR20090002435A (ko) 헬리코박터 파일로리균의 리보좀 단백질 ｌ１유래의 새로운접힘 구조를 갖는 항생 펩타이드 및 조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued